Trial Profile
Pharmacological treatment of psychotic depression
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Dec 2009
Price :
$35
*
At a glance
- Drugs Imipramine (Primary) ; Lithium (Primary) ; Quetiapine (Primary) ; Venlafaxine (Primary)
- Indications Psychotic affective disorders
- Focus Therapeutic Use
- 09 Dec 2009 New source identified and integrated (Netherlands Trial Register, NTR26).
- 01 Oct 2009 Results of phase 2 (lithium addition) published in the Journal of Clinical Psychopharmacology.
- 06 Oct 2006 New trial record.